VA

Vishal Ashokbhai Shah

Director Cfo DIN 10418466
DIN 10418466 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishal Ashokbhai Shah

Data last updated:

Vishal Ashokbhai Shah was a Cfo at Zydus Animal Health And Investments Limited (2020–2021) and Director at Ayurvet Limited (from 2023). The companies operate in Pharma.

DIN 10418466
Primary Designation Cfo
Industry Pharma
First Appointment 20 Mar 2020
Oldest Company Age 34 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cfo20 Mar 20202018₹334 Cr (FY 2025)Active
Ayurvet Limited U74899GJ1992PLC150192
Director14 Dec 20231992₹108 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ayurvet Limited
Zydus Animal Health And Investments Limited
Premium access

Shareholding and investment profile for Vishal Ashokbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Ashokbhai Shah

Vishal Ashokbhai Shah was first appointed on 20 Mar 2020 as Cfo at Zydus Animal Health And Investments Limited. The most recent appointment on record is 14 Dec 2023 at Ayurvet Limited.

Vishal Ashokbhai Shah held 2 earlier board appointments: Zydus Animal Health And Investments Limited (Cfo, 20 Mar 2020 to 14 Jul 2021); Ayurvet Limited (Director, from 14 Dec 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available